Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: A review

Frontiers in Microbiology

Volumn 8, Issue APR, 2017, Pages

  Dahiya, Dinesh K ^a   Renuka, ^b   Puniya, Monica ^c   Shandilya, Umesh K ^d   Dhewa, Tejpal ^e   Kumar, Nikhil ^f   Kumar, Sanjeev ^g   Puniya, Anil K ^h,i   Shukla, Pratyoosh ^j  

^a RAJASTHAN UNIVERSITY OF VETERINARY AND ANIMAL SCIENCES   (India)

^b PANJAB UNIVERSITY   (India)

^c Food Safety and Standard Authority of India   (India)

^d NATIONAL BUREAU OF ANIMAL GENETIC RESOURCES   (India)

^e CENTRAL UNIVERSITY OF HARYANA   (India)

^f Shri Venkateshwara University   (India)

^g ASSAM UNIVERSITY   (India)

^h GURU ANGAD DEV VETERINARY AND ANIMAL SCIENCES UNIVERSITY   (India)

ⁱ NATIONAL DAIRY RESEARCH INSTITUTE   (India)

^j MAHARSHI DAYANAND UNIVERSITY   (India)

more..

Author keywords

Gut microbiota; Nanotechnology; Obesity; Prebiotic; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; ARABINOXYLAN; BILE ACID; ENDOCANNABINOID; FASTING INDUCED ADIPOSE FACTOR; FRUCTAN; FRUCTOSE OLIGOSACCHARIDE; G PROTEIN COUPLED RECEPTOR; PREBIOTIC AGENT; PROBIOTIC AGENT; PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; DYSBIOSIS; ENDOTOXEMIA; ENERGY METABOLISM; FATTY ACID OXIDATION; HUMAN; INNATE IMMUNITY; INTESTINE FLORA; LIPID DIET; LIPOGENESIS; MICROBIAL COMMUNITY; NONHUMAN; OBESITY; REVIEW; SATIETY;

EID: 85018271791     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00563     Document Type: Review

References (140)

1. Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., and Versalovic, J. (2014). The placenta harbors a unique microbiome. Sci. Trans. Med. 6, 237ra265. doi: 10.1126/scitranslmed.3008599
2. Alard, J., Lehrter, V., Rhimi, M., Mangin, I., Peucelle, V., Abraham, A. L., et al. (2016). Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environ. Microbiol. 18, 1484-1497. doi: 10.1111/1462-2920.13181
3. An, H. M., Park, S. Y., Lee, D. K., Kim, J. R., Cha, M. K., Lee, S. W., et al. (2011). Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis. 10:116. doi: 10.1186/1476-511X-10-116
4. Angin, Y., Beauloye, C., Horman, S., and Bertrand, L. (2016). "Regulation of carbohydrate metabolism, lipid metabolism, and protein metabolism by AMPK," in AMP-Activated Protein Kinase, (Berlin: Springer), 23-43. doi: 10.1007/978-3-319-43589-3_2
5. Armougom, F., Henry, M., Vialettes, B., Raccah, D., and Raoult, D. (2009). Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS ONE 4:e7125. doi: 10.1371/journal.pone.0007125
6. Aron-Wisnewsky, J., Gaborit, B., Dutour, A., and Clement, K. (2013). Gut microbiota and non-alcoholic fatty liver disease: new insights. Clin. Microbiol. Infect 19, 338-348. doi: 10.1111/1469-0691.12140
7. Arora, T., Singh, S., and Sharma, R. K. (2013). Probiotics: interaction with gut microbiome and antiobesity potential. Nutrition 29, 591-596. doi: 10.1016/j.nut.2012.07.017
8. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., et al. (2011). Enterotypes of the human gut microbiome. Nature 473, 174-180. doi: 10.1038/nature09944
9. Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101, 15718-15723. doi: 10.1073/pnas.0407076101
10. Bäckhed, F., Manchester, J. K., Semenkovich, C. F., and Gordon, J. I. (2007). Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U.S.A. 104, 979-984. doi: 10.1073/pnas.0605374104
11. Balamurugan, R., George, G., Kabeerdoss, J., Hepsiba, J., Chandragunasekaran, A. M., and Ramakrishna, B. S. (2010). Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br. J. Nutr. 103, 335-338. doi: 10.1017/S0007114509992182
12. Boulangé, C. L., Neves, A. L., Chilloux, J., Nicholson, J. K., and Dumas, M.-E. (2016). Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 8:42. doi: 10.1186/s13073-016-0303-2
13. Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., et al. (2003). The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312-11319. doi: 10.1074/jbc.M211609200
14. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes Metab. Res. Rev. 56, 1761-1772. doi: 10.2337/db06-1491
15. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., et al. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes Metab. Res. Rev. 57, 1470-1481. doi: 10.2337/db07-1403
16. Cani, P. D., Dewever, C., and Delzenne, N. M. (2004). Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br. J. Nutr. 92, 521-526. doi: 10.1079/BJN20041225
17. Cani, P. D., Everard, A., and Duparc, T. (2013). Gut microbiota, enteroendocrine functions and metabolism. Curr. Opin. Pharmacol. 13, 935-940. doi: 10.1016/j.coph.2013.09.008
18. Cani, P. D., Hoste, S., Guiot, Y., and Delzenne, N. M. (2007). Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br. J. Nutr. 98, 32-37
19. Cani, P. D., Joly, E., Horsmans, Y., and Delzenne, N. (2006). Oligofructose promotes satiety in healthy human: a pilot study. Eur. J. Clin. Nutr. 60, 567-572
20. Cani, P. D., Knauf, C., Iglesias, M. A., Drucker, D. J., Delzenne, N. M., and Burcelin, R. (2006). Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes Metab. Res. Rev. 55, 1484-1490
21. Cani, P. D., Lecourt, E., Dewulf, E. M., Sohet, F. M., Pachikian, B. D., Naslain, D., et al. (2009). Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 90, 1236-1243. doi: 10.3945/ajcn.2009.28095
22. Cani, P. D., Neyrinck, A., Fava, F., Knauf, C., Burcelin, R., Tuohy, K., et al. (2007). Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374-2383
23. Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., et al. (2009). Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103. doi: 10.1136/gut.2008.165886
24. Chiang, J. Y. (2009). Bile acids: regulation of synthesis. J. Lipid Res. 50, 1955-1966. doi: 10.1194/jlr.R900010-JLR200
25. Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadil, J., Li, K., et al. (2012). Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488, 621-626. doi: 10.1038/nature11400
26. Clarke, S. F., Murphy, E. F., O'Sullivan, O., Ross, R. P., O'Toole, P. W., Shanahan, F., et al. (2013). Targeting the microbiota to address diet-induced obesity: a time dependent challenge. PLoS ONE 8:e65790. doi: 10.1371/journal.pone.0065790
27. Cotillard, A., Kennedy, S. P., Kong, L. C., Prifti, E., Pons, N., Le Chatelier, E., et al. (2013). Dietary intervention impact on gut microbial gene richness. Nature 500, 585-588. doi: 10.1038/nature12480
28. Cox, L. M., Yamanishi, S., Sohn, J., Alekseyenko, A. V., Leung, J. M., Cho, I., et al. (2014). Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705-721. doi: 10.1016/j.cell.2014.05.052
29. da Silva, S. T., dos Santos, C. A., and Bressan, J. (2013). Intestinal microbiota relevance to obesity and modulation by prebiotics and probiotics. Nutr. Hosp. 28, 1039-1048. doi: 10.3305/nh.2013.28.4.6525
30. Dahiya, D. K., and Puniya, A. K. (2015). Evaluation of survival, free radical scavenging and human enterocyte adherence potential of Lactobacilli with anti-obesity and anti-inflammatory CLA isomer-producing attributes. J. Food Process. Preserv. 36, 2866-2877. doi: 10.1111/jfpp.12538
31. Dahiya, D. K., and Puniya, A. K. (2017). Isolation, molecular characterization and screening of indigenous lactobacilli for their abilities to produce bioactive conjugated linoleic acid (CLA). J. Food Sci. Technol. 54, 792-801. doi: 10.1007/s13197-017-2523-x
32. Dao, M. C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E. O., et al. (2016). Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65, 426-436. doi: 10.1136/gutjnl-2014-308778
33. Davis, J. E., Gabler, N. K., Walker-Daniels, J., and Spurlock, M. E. (2008). Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity 16, 1248-1255. doi: 10.1038/oby.2008.210
34. De Silva, A., and Bloom, S. R. (2012). Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut Liver 6, 10-20. doi: 10.5009/gnl.2012.6.1.10
35. Dewulf, E. M., Cani, P. D., Claus, S. P., Fuentes, S., Puylaert, P. G., Neyrinck, A. M., et al. (2012). Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62, 1112-1121. doi: 10.1136/gutjnl-2012-303304
36. Dray, C., Knauf, C., Daviaud, D., Waget, A., Boucher, J., Buléon, M., et al. (2008). Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 8, 437-445. doi: 10.1016/j.cmet.2008.10.003
37. Druart, C., Neyrinck, A. M., Dewulf, E. M., De Backer, F. C., Possemiers, S., Van de Wiele, T., et al. (2013). Implication of fermentable carbohydrates targeting the gut microbiota on conjugated linoleic acid production in high-fat-fed mice. Br. J. Nutr. 110, 998-1011. doi: 10.1017/S0007114513000123
38. Duncan, S. H., Belenguer, A., Holtrop, G., Johnstone, A. M., Flint, H. J., and Lobley, G. E. (2007). Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 73, 1073-1078. doi: 10.1128/AEM.02340-06
39. Duncan, S. H., Louis, P., Thomson, J. M., and Flint, H. J. (2009). The role of pH in determining the species composition of the human colonic microbiota. Environ. Microbiol. 11, 2112-2222. doi: 10.1111/j.1462-2920.2009.01931.x
40. Dutton, S., and Trayhurn, P. (2008). Regulation of angiopoietin-like protein 4/fasting-induced adipose factor (Angptl4/FIAF) expression in mouse white adipose tissue and 3T3-L1 adipocytes. Br. J. Nutr. 100, 18-26. doi: 10.1017/S0007114507882961
41. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., et al. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638. doi: 10.1126/science.1110591
42. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., et al. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 110, 9066-9071. doi: 10.1073/pnas.1219451110
43. Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G. G., Neyrinck, A. M., et al. (2011). Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes Metab. Res. Rev. 60, 2775-2786. doi: 10.2337/db11-0227
44. Everard, A., Lazarevic, V., Gaïa, N., Johansson, M., Ståhlman, M., Backhed, F., et al. (2014). Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 8, 2116-2130. doi: 10.1038/ismej.2014.45
45. Feng, J., Tang, H., Li, M., Pang, X., Wang, L., Zhang, M., et al. (2014). The abundance of fecal Faecalibacterium prausnitzii in relation to obesity and gender in Chinese adults. Arch. Microbiol. 196, 73-77. doi: 10.1007/s00203-013-0942-2
46. Fleissner, C. K., Huebel, N., El-Bary, M. M. A., Loh, G., Klaus, S., and Blaut, M. (2010). Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 104, 919-929. doi: 10.1017/S0007114510001303
47. Franzosa, E. A., Huang, K., Meadow, J. F., Gevers, D., Lemon, K. P., Bohannan, B. J., et al. (2015). Identifying personal microbiomes using metagenomic codes. Proc. Natl. Acad. Sci. U.S.A. 112, E2930-E2938. doi: 10.1073/pnas.1423854112
48. Gad, G. F. M., Abdel-Hamid, A. M., and Farag, Z. S. H. (2014). Antibiotic resistance in lactic acid bacteria isolated from some pharmaceutical and dairy products. Braz. J. Microbiol. 45, 25-33. doi: 10.1590/S1517-83822014000100005
49. Gérard, P. (2016). Gut microbiota and obesity. Cell. Mol. Life Sci. 73, 147-162. doi: 10.1007/s00018-015-2061-5
50. Geurts, L., Lazarevic, V., Derrien, M., Everard, A., Van Roye, M., Knauf, C., et al. (2011). Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front. Microbiol. 2:149. doi: 10.3389/fmicb.2011.00149
51. Gibson, G. R., Probert, H. M., Van Loo, J., Rastall, R. A., and Roberfroid, M. B. (2004). Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr. Res. Rev. 17, 259-275. doi: 10.1079/NRR200479
52. Go, G.-W., Oh, S., Park, M., Gang, G., McLean, D., Yang, H.-S., et al. (2013). t10, c12 conjugated linoleic acid upregulates hepatic de novo lipogenesis and triglyceride synthesis via mTOR pathway activation. J. Microbiol. Biotechnol. 23, 1569-1576. doi: 10.4014/jmb.1308.08008
53. Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature 444, 860-867. doi: 10.1038/nature05485
54. Joossens, M., Huys, G., Van Steen, K., Cnockaert, M., Vermeire, S., Rutgeerts, P., et al. (2011). High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two bifidobacterial species after inulin-type prebiotic intake. FEMS Microbiol. Ecol. 75, 343-349. doi: 10.1111/j.1574-6941.2010.01008.x
55. Karra, E., Chandarana, K., and Batterham, R. L. (2009). The role of peptide YY in appetite regulation and obesity. J. Physiol. 587, 19-25. doi: 10.1113/jphysiol.2008.164269
56. Kasubuchi, M., Hasegawa, S., Hiramatsu, T., Ichimura, A., and Kimura, I. (2015). Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7, 2839-2849. doi: 10.3390/nu7042839
57. Kim, J., Yang, G., and Ha, J. (2017). Targeting of AMP-activated protein kinase: prospects for computer-aided drug design. Expert Opin. Drug Dis. 12, 47-59. doi: 10.1080/17460441.2017.1255194
58. Kim, K.-A., Jeong, J.-J., and Kim, D.-H. (2015). Lactobacillus brevis OK56 ameliorates high-fat diet-induced obesity in mice by inhibiting NF-κB activation and gut microbial LPS production. J. Funct. Foods 13, 183-191. doi: 10.1016/j.jff.2014.12.045
59. Kimura, I., Ozawa, K., Inoue, D., Imamura, T., Kimura, K., Maeda, T., et al. (2013). The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4, 1829. doi: 10.1038/ncomms2852
60. Knights, D., Ward, T. L., McKinlay, C. E., Miller, H., Gonzalez, A., McDonald, D., et al. (2014). Rethinking "enterotypes". Cell Host Microbe 16, 433-437. doi: 10.1016/j.chom.2014.09.013
61. Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., et al. (2011). Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4578-4585. doi: 10.1073/pnas.1000081107
62. Koh, A., De Vadder, F., Kovatcheva-Datchary, P., and Bäckhed, F. (2016). From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332-1345. doi: 10.1016/j.cell.2016.05.041
63. Kopelman, P. (2007). Health risks associated with overweight and obesity. Obes. Rev. 8, 13-17. doi: 10.1111/j.1467-789X.2007.00311.x
64. Koren, O., Knights, D., Gonzalez, A., Waldron, L., Segata, N., Knight, R., et al. (2013). A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput. Biol. 9:e1002863. doi: 10.1371/journal.pcbi.1002863
65. Larsen, N., Vogensen, F. K., Gøbel, R. J., Michaelsen, K. F., Forssten, S. D., Lahtinen, S. J., et al. (2013). Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clin. Nutr. 32, 935-940. doi: 10.1016/j.clnu.2013.02.007
66. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., et al. (2013). Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546. doi: 10.1038/nature12506
67. Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., et al. (2003). Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278, 25481-25489. doi: 10.1074/jbc.M301403200
68. Lee, S. J., Bose, S., Seo, J.-G., Chung, W.-S., Lim, C.-Y., and Kim, H. (2014). The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial. Clin. Nutr. 33, 973-981. doi: 10.1016/j.clnu.2013.12.006
69. Letran, S. E., Lee, S.-J., Atif, S. M., Flores-Langarica, A., Uematsu, S., Akira, S., et al. (2011). TLR5-deficient mice lack basal inflammatory and metabolic defects but exhibit impaired CD4 T cell responses to a flagellated pathogen. J. Immunol. 186, 5406-5412. doi: 10.4049/jimmunol.1003576
70. Leung, C., Rivera, L., Furness, J. B., and Angus, P. W. (2016). The role of the gut microbiota in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 13, 412-425. doi: 10.1038/nrgastro.2016.85
71. Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., and Gordon, J. I. (2005). Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 102, 11070-11075. doi: 10.1073/pnas.0504978102
72. Ley, R. E., Turnbaugh, P. J., Klein, S., and Gordon, J. I. (2006). Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023. doi: 10.1038/4441022a
73. Lim, S.-M., Jeong, J.-J., Woo, K. H., Han, M. J., and Kim, D.-H. (2016). Lactobacillus sakei OK67 ameliorates high-fat diet-induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression. Nutr. Res. 36, 337-348. doi: 10.1016/j.nutres.2015.12.001
74. Louis, P., and Flint, H. J. (2009). Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 294, 1-8. doi: 10.1111/j.1574-6968.2009.01514.x
75. Luna, R. A., and Foster, J. A. (2015). Gut brain axis: diet microbiota interactions and implications for modulation of anxiety and depression. Curr. Opin. Biotechnol. 32, 35-41. doi: 10.1016/j.copbio.2014.10.007
76. Luoto, R., Kalliomäki, M., Laitinen, K., and Isolauri, E. (2010). The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int. J. Obes. 34, 1531-1537. doi: 10.1038/ijo.2010.50
77. Mackie, K. (2008). Cannabinoid receptors: where they are and what they do. J. Neuroendocrinol. 20, 10-14. doi: 10.1111/j.1365-2826.2008.01671.x
78. Maenhaut, N., and Van de Voorde, J. (2011). Regulation of vascular tone by adipocytes. BMC Med. 9:25. doi: 10.1186/1741-7015-9-25
79. Marteau, P., and Seksik, P. (2004). Tolerance of probiotics and prebiotics. J. Clin. Gastroenterol. 38, S67-S69. doi: 10.1097/01.mcg.0000128929.37156.a7
80. Medzhitov, R. (2001). Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1, 135-145. doi: 10.1038/35100529
81. Million, M., Angelakis, E., Paul, M., Armougom, F., Leibovici, L., and Raoult, D. (2012). Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microb. Pathog. 53, 100-108. doi: 10.1016/j.micpath.2012.05.007
82. Million, M., Maraninchi, M., Henry, M., Armougom, F., Richet, H., Carrieri, P., et al. (2012). Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int. J. Obes. 36, 817-825. doi: 10.1038/ijo.2011.153
83. Miquel, S., Martín, R., Rossi, O., Bermúdez-Humarán, L. G., Chatel, J. M., Sokol, H., et al. (2013). Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 16, 255-261. doi: 10.1016/j.mib.2013.06.003
84. Muccioli, G. G., Naslain, D., Bäckhed, F., Reigstad, C. S., Lambert, D. M., Delzenne, N. M., et al. (2010). The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol. 6, 392. doi: 10.1038/msb.2010.46
85. Mueller, N. T., Whyatt, R., Hoepner, L., Oberfield, S., Dominguez-Bello, M. G., Widen, E., et al. (2014). Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int. J. Obes. 39, 665-670. doi: 10.1038/ijo.2014.180
86. Murphy, E. F., Cotter, P. D., Hogan, A., O'sullivan, O., Joyce, A., Fouhy, F., et al. (2013). Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 62, 220-226. doi: 10.1136/gutjnl-2011-300705
87. Neyrinck, A. M., Possemiers, S., Druart, C., Van de Wiele, T., De Backer, F., Cani, P. D., et al. (2011). Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS ONE 6:e20944. doi: 10.1371/journal.pone.0020944
88. Nikolopoulou, A., and Kadoglou, N. P. (2012). Obesity and metabolic syndrome as related to cardiovascular disease. Expert Rev. Cardiovasc. Ther. 10, 933-939. doi: 10.1586/erc.12.74
89. Nøhr, M. K., Pedersen, M. H., Gille, A., Egerod, K. L., Engelstoft, M. S., Husted, A. S., et al. (2013). GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154, 3552-3564. doi: 10.1210/en.2013-1142
90. Ouchi, N., Parker, J. L., Lugus, J. J., and Walsh, K. (2011). Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11, 85-97. doi: 10.1038/nri2921
91. Park, D. Y., Ahn, Y. T., Park, S. H., Huh, C. S., Yoo, S. R., Yu, R., et al. (2013). Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS ONE 8:e59470. doi: 10.1371/journal.pone.0059470
92. Park, S., Ji, Y., Jung, H.-Y., Park, H., Kang, J., Choi, S.-H., et al. (2017). Lactobacillus plantarum HAC01 regulates gut microbiota and adipose tissue accumulation in a diet-induced obesity murine model. Appl. Microbiol. Biotechnol. 101, 1605-1614. doi: 10.1007/s00253-016-7953-2
93. Parnell, J. A., and Reimer, R. A. (2009). Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 89, 1751-1759. doi: 10.3945/ajcn.2009.27465
94. Perez-Chanona, E., and Trinchieri, G. (2016). The role of microbiota in cancer therapy. Curr. Opin. Immunol. 39, 75-81. doi: 10.1016/j.coi.2016.01.003
95. Peterson, C., Sharma, V., Elmén, L., and Peterson, S. (2015). Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin. Exp. Immunol. 179, 363-377. doi: 10.1111/cei.12474
96. Podolsky, S. H. (2017). Historical perspective on the rise and fall and rise of antibiotics and human weight gainhistorical perspective on antibiotics and human weight gain. Ann. Intern. Med. 166, 133-138. doi: 10.7326/M16-1855
97. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65. doi: 10.1038/nature08821
98. Quigley, E. M. (2011). Gut microbiota and the role of probiotics in therapy. Curr. Opin. Pharmacol. 11, 593-603. doi: 10.1016/j.coph.2011.09.010
99. Rajkumar, H., Kumar, M., Das, N., Kumar, S. N., Challa, H. R., and Nagpal, R. (2015). Effect of probiotic Lactobacillus salivarius UBL S22 and prebiotic fructo-oligosaccharide on serum lipids, inflammatory markers, insulin sensitivity, and gut bacteria in healthy young volunteers: a randomized controlled single-blind pilot study. J. Cardiovasc. Pharmacol. Ther. 20, 289-298. doi: 10.1177/1074248414555004
100. Ramirez-Farias, C., Slezak, K., Fuller, Z., Duncan, A., Holtrop, G., and Louis, P. (2009). Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 101, 541-550. doi: 10.1017/S0007114508019880
101. Rather, S. A., Pothuraju, R., Sharma, R. K., De, S., Mir, N. A., and Jangra, S. (2014). Anti-obesity effect of feeding probiotic dahi containing Lactobacillus casei NCDC 19 in high fat diet-induced obese mice. Int. J. Dairy Technol. 67, 504-509. doi: 10.1111/1471-0307.12154
102. Regard, J. B., Sato, I. T., and Coughlin, S. R. (2008). Anatomical profiling of G protein-coupled receptor expression. Cell 135, 561-571. doi: 10.1016/j.cell.2008.08.040
103. Remely, M., Hippe, B., Zanner, J., Aumueller, E., Brath, H., and Haslberger, A. G. (2016). Gut microbiota of obese, type 2 diabetic individuals is enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after weight loss. Endocr. Metab. Immune Disord. Drug Targets 16, 99-106. doi: 10.2174/1871530316666160831093813
104. Respondek, F., Gerard, P., Bossis, M., Boschat, L., Bruneau, A., Rabot, S., et al. (2013). Short-chain fructo-oligosaccharides modulate intestinal microbiota and metabolic parameters of humanized gnotobiotic diet induced obesity mice. PLoS ONE 8:e71026. doi: 10.1371/journal.pone.0071026
105. Ridlon, J. M., Kang, D. J., Hylemon, P. B., and Bajaj, J. S. (2014). Bile acids and the gut microbiome. Curr. Opin. Gastroenterol. 30, 332-338. doi: 10.1097/MOG.0000000000000057
106. Riva, A., Borgo, F., Lassandro, C., Verduci, E., Morace, G., Borghi, E., et al. (2017). Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations. Environ. Microbiol. 19, 95-105. doi: 10.1111/1462-2920.13463
107. Rosenbaum, M., Knight, R., and Leibel, R. L. (2015). The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol. Metab. 26, 493-501. doi: 10.1016/j.tem.2015.07.002
108. Salazar, N., Dewulf, E. M., Neyrinck, A. M., Bindels, L. B., Cani, P. D., Mahillon, J., et al. (2015). Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clin. Nutr. 34, 501-507. doi: 10.1016/j.clnu.2014.06.001
109. Sanders, M. E. (2008). Probiotics: definition, sources, selection, and uses. Clin. Infect. Dis. 46(Suppl. 2), S58-S61. doi: 10.1086/523341
110. Sanz, Y., Rastmanesh, R., and Agostonic, C. (2013). Understanding the role of gut microbes and probiotics in obesity: how far are we? Pharmacol. Res. 69, 144-155. doi: 10.1016/j.phrs.2012.10.021
111. Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., et al. (2013). Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225-235. doi: 10.1016/j.cmet.2013.01.003
112. Schneeberger, M., Everard, A., Gómez-Valadés, A. G., Matamoros, S., Ramírez, S., Delzenne, N. M., et al. (2015). Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci. Rep. 5:16643. doi: 10.1038/srep16643
113. Singh, S., Sharma, R., Malhotra, S., Pothuraju, R., and Shandilya, U. (2016). Lactobacillus rhamnosus NCDC17 ameliorates type-2 diabetes by improving gut function, oxidative stress and inflammation in high-fat-diet fed and streptozotocintreated rats. Benef. Microbes doi: 10.3920/BM2016.0090 [Epub ahead of print]
114. Sommer, F., and Bäckhed, F. (2013). The gut microbiota-masters of host development and physiology. Nat. Rev. Microbiol. 11, 227-238. doi: 10.1038/nrmicro2974
115. Stanton, C., Ross, R. P., Fitzgerald, G. F., and Van Sinderen, D. (2005). Fermented functional foods based on probiotics and their biogenic metabolites. Curr. Opin. Biotechnol. 16, 198-203. doi: 10.1038/nrmicro2974
116. Steinert, R., Beglinger, C., and Langhans, W. (2016). Intestinal GLP-1 and satiation: from man to rodents and back. Int. J. Obes. 40, 198-205. doi: 10.1038/ijo.2015.172
117. Swann, J. R., Want, E. J., Geier, F. M., Spagou, K., Wilson, I. D., Sidaway, J. E., et al. (2011). Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4523-4530. doi: 10.1073/pnas.1006734107
118. Swinburn, B. A., Sacks, G., Hall, K. D., McPherson, K., Finegood, D. T., Moodie, M. L., et al. (2011). The global obesity pandemic: shaped by global drivers and local environments. Lancet 378, 804-814. doi: 10.1016/S0140-6736(11)60813-1
119. Tarini, J., and Wolever, T. M. (2010). The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl. Physiol. Nutr. Metab. 35, 9-16. doi: 10.1139/H09-119
120. Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., et al. (2012). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes Metab. Res. Rev. 61, 364-371. doi: 10.2337/db11-1019
121. Toral, M., Gómez-Guzmán, M., Jiménez, R., Romero, M., Sánchez, M., Utrilla, M. P., et al. (2014). The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clin. Sci. 127, 33-45. doi: 10.1042/CS20130339
122. Tsai, Y.-T., Cheng, P.-C., and Pan, T.-M. (2014). Anti-obesity effects of gut microbiota are associated with lactic acid bacteria. Appl. Microbiol. Biotechnol. 98, 1-10. doi: 10.1042/CS20130339
123. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., and Gordon, J. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1131. doi: 10.1007/s00253-013-5346-3
124. Turta, O., and Rautava, S. (2016). Antibiotics, obesity and the link to microbes-what are we doing to our children? BMC Med. 14:57. doi: 10.1186/s12916-016-0605-7
125. Velagapudi, V. R., Hezaveh, R., Reigstad, C. S., Gopalacharyulu, P., Yetukuri, L., Islam, S., et al. (2010). The gut microbiota modulates host energy and lipid metabolism in mice. J. Lipid Res. 51, 1101-1112. doi: 10.1194/jlr.M002774
126. Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., et al. (2010). Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231. doi: 10.1126/science.1179721
127. Villena, J., and Kitazawa, H. (2014). Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937. Front. Immunol. 4:512. doi: 10.3389/fimmu.2013.00512
128. Vucenik, I., and Stains, J. P. (2012). Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann. N. Y. Acad. Sci. 1271, 37-43. doi: 10.1111/j.1749-6632.2012.06750.x
129. Wang, H., and Eckel, R. H. (2009). Lipoprotein lipase: from gene to obesity. Am. J. Physiol. Endocrinol. Metab. 297, E271-E288. doi: 10.1152/ajpendo.90920.2008
130. Wang, Y. C., McPherson, K., Marsh, T., Gortmaker, S. L., and Brown, M. (2011). Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 378, 815-825. doi: 10.1016/S0140-6736(11)60814-3
131. Wang, Z., Xiao, G., Yao, Y., Guo, S., Lu, K., and Sheng, Z. (2006). The role of bifidobacteria in gut barrier function after thermal injury in rats. J. Trauma Acute Care Surg. 61, 650-657. doi: 10.1016/S0140-6736(11)60814-3
132. Withrow, D., and Alter, D. (2011). The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes. Rev. 12, 131-141. doi: 10.1111/j.1467-789X.2009.00712.x
133. Xiong, Y., Miyamoto, N., Shibata, K., Valasek, M. A., Motoike, T., Kedzierski, R. M., et al. (2004). Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl. Acad. Sci. U.S.A. 101, 1045-1050. doi: 10.1111/j.1467-789X.2009.00712.x
134. Yadav, H., Lee, J. H., Lloyd, J., Walter, P., and Rane, S. G. (2013). Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J. Biol. Chem. 288, 25088-25097. doi: 10.1074/jbc.M113.452516
135. Yadav, R., Singh, P. K., Puniya, A. K., and Shukla, P. (2016). Catalytic interactions andmolecular docking of bile salt hydrolase (BSH) from L. plantarum RYPR1 and itsprebiotic utilization. Front. Microbiol. 7:2116. doi: 10.3389/fmicb.2016.02116
136. Yadav, R., Singh, P. K., and Shukla, P. (2016). Metabolic engineering for probiotics and their genome-wide expression profiling. Curr. Protein Pept. Sci. doi: 10.2174/1389203718666161111130157 [Epub ahead of print]
137. Yin, Y.-N., Yu, Q.-F., Fu, N., Liu, X.-W., and Lu, F.-G. (2010). Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J. Gastroenterol. 16, 3394-3401. doi: 10.3748/wjg.v16.i27.3394
138. Zaibi, M. S., Stocker, C. J., O'Dowd, J., Davies, A., Bellahcene, M., Cawthorne, M. A., et al. (2010). Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett. 584, 2381-2386. doi: 10.1016/j.febslet.2010.04.027
139. Zhou, J., Martin, R. J., Tulley, R. T., Raggio, A. M., McCutcheon, K. L., Shen, L., et al. (2008). Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am. J. Physiol. Endocrinol. Metab. 295, E1160-E1166. doi: 10.1152/ajpendo.90637.2008
140. Zimmer, J., Lange, B., Frick, J.-S., Sauer, H., Zimmermann, K., Schwiertz, A., et al. (2012). A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur. J. Clin. Nutr. 66, 53-60. doi: 10.1038/ejcn.2011.141